Order Article Reprints

Sato M, Odagiri K, Tabuchi Y, Okamoto H, Shimokawa T, Nakamura Y, Hata M. Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer. Cancers. 2024; 16(6):1162. https://doi.org/10.3390/cancers16061162

Sato, Mizuki, Kazumasa Odagiri, Yuya Tabuchi, Hiroaki Okamoto, Tsuneo Shimokawa, Yukiko Nakamura, and Masaharu Hata. 2024. "Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer" Cancers 16, no. 6: 1162. https://doi.org/10.3390/cancers16061162

Sato, M., Odagiri, K., Tabuchi, Y., Okamoto, H., Shimokawa, T., Nakamura, Y., & Hata, M. (2024). Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer. Cancers, 16(6), 1162. https://doi.org/10.3390/cancers16061162